Skip to content
Zerafil Dosing
Response Assessment
Treatment Initiation
Asthma Control Test (ACT)
Zerafil Dosing
Response Assessment
Treatment Initiation
Asthma Control Test (ACT)
Contact us
Treatment Initiation
Algorithm for Asthma Treatment with Zerafil
"
*
" indicates required fields
Step
1
of
6
0%
1- Is the patient currently having an exacerbation?
*
YES
NO
In the past 4 weeks, has the patient had?
Daytime asthma symptoms more than twice a week?
*
YES
NO
Any night waking due to asthma?
*
YES
NO
Reliever needed for symptoms more than twice a week?
*
YES
NO
Any activity limitation due to asthma?
*
YES
NO
Hidden
Level of asthma _sum
Has the patient had exacerbations in the past year?
*
YES
NO
Result of skin prick or specific IgE test:
*
Positive
Negative
Not assessed
Clinical assurance of the attending physician that the patient's asthma is allergic with the presence of one of the following:
Asthma is clinically allergen-driven
Blood eosinophils ≥150/µl
FeNO ≥ 20 ppb
Sputum eosinophils ≥ 2%
Select one or more options from the list above to proceed, OR
*
None of the above
Hidden
Result_clinical
Before assuming asthma is non-type 2 consider repeating blood eosinophils and FeNO up to 3 times (e.g., when asthma worsens, before giving OCS, or at least 1-2 weeks after a course of OCS, or on the lowest possible OCS dose)
*
Type 2 inflammation was proven by repeating the tests
Asthma is non-type 2
Overview of the Algorithms
